Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DPH5 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
mRNA | HNRNPR | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
mRNA | IDH3G | CTRPv2 | pan-cancer | AAC | 0.34 | 0.002 |
mRNA | CISD3 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |
mRNA | MDM4 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
mRNA | NSDHL | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
mRNA | TMEM9 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.002 |
mRNA | FBXO43 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
mRNA | MCM7 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
mRNA | MAGOH | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |